Publications
development
2022
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
PLOS
MMGH Author(s)
policy
2022
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants – Key considerations for global use
Vaccine
MMGH Author(s)
development
2021
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women
Clinical Infectious Diseases 74, Suppl.1, 2022: S70–S79
MMGH Author(s)
strategy
2022
Application of the Child Health and Nutrition Research Initiative (CHNRI) methodology to prioritize research to enable the implementation of Ending Cholera: A global roadmap to 2030
PLOS
MMGH Author(s)
evaluation
2021
An External Evaluation on the INCLEN Research Program to Emphasize the Public Health Significance of Childhood Pneumonia in India
Indian Pediatrics Volume 58
MMGH Author(s)
strategy
2021
The World of Immunization: Achievements, Challenges, and Strategic Vision for the Next Decade
The Journal of Infectious Diseases, Volume 224, Issue Supplement 4, pp. S452-S467
MMGH Author(s)
evaluation
2022
Covid-19 vaccines: the factors that enabled unprecedented timelines for clinical development and regulatory authorisation
Wellcome Trust
MMGH Author(s)
development
2021
Stakeholder Perceptions About Group B Streptococcus Disease and Potential for Maternal Vaccination in Low- and Middle-Income Countries
Clinical Infectious Diseases 74, Suppl.1, 2022: S80–S87
MMGH Author(s)
evaluation
2021
Human leishmaniasis vaccines: Use cases, target population and potential global demand
PLOS
MMGH Author(s)